We’d love to keep you in the loop. Sign up to get updates on Gamifant® (emapalumab-lzsg) and advancements in the treatment of primary HLH.
Primary hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory condition that mostly affects children, but can also occur in adults and teenagers.1-4
Gamifant reduces the inflammatory symptoms of primary HLH by neutralizing IFNγ.5
Gamifant is given as an intravenous infusion twice a week until hematopoietic stem cell transplantation (HSCT) is performed.5
Gamifant can be ordered through our specialty pharmacy or one of our specialty distributors.